Evidence map›Paper›PMID 30068619›Full record

ArticleBMJ open2018

Cutting care clusters: the creation of an inverse pharmacy care law? An area-level analysis exploring the clustering of community pharmacies in England.

Adam Todd, Katie Thomson, Adetayo Kasim, Clare Bambra

Abstract read
In one paragraph

Article in BMJ open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Adam ToddSchool of Pharmacy, Newcastle University, Newcastle upon Tyne, UK.ORCID 0000-0003-1496-9341
Katie ThomsonInstitute of Health and Society, Newcastle University, Newcastle upon Tyne, UK.
Adetayo KasimWolfson Research Institute for Health and Wellbeing, Durham University, Stockton-on-Tees, UK.
Clare BambraInstitute of Health and Society, Newcastle University, Newcastle upon Tyne, UK.

Funding

British Heart FoundationCancer Research UKMedical Research Council MR/K02325X/1
6 · The paper itself

Abstract

objectivesTo (1) explore the clustering of community pharmacies in England and (2) determine the relationship between community pharmacy clustering, urbanity and deprivation.

designAn area-level analysis spatial study.

settingEngland. PRIMARY AND SECONDARY OUTCOME MEASURES: Community pharmacy clustering determined as a community pharmacy located within 10 min walking distance to another community pharmacy.

participantsAddresses and postal codes of each community pharmacy in England were used in the analysis. Each pharmacy postal code was assigned to a lower layer super output area, which was then matched to urbanity (urban, town and fringe or village, hamlet and isolated dwellings) and deprivation decile (using the Index of Multiple Deprivation score).

results75% of community pharmacies in England were located in a 'cluster' (within 10 min walking distance of another pharmacy): 19% of community pharmacies were in a cluster of two, while 56% of community pharmacies were in clusters of three or more. There was a linear relationship between community pharmacy clustering and social deprivation-with clustering more prevalent in areas of higher deprivation: for community pharmacies located in areas of lowest deprivation (decile 1), there was a significantly lower risk of clustering compared with community pharmacies located in areas of highest deprivation (relative risk 0.12 (95% CI 0.10 to 0.16)).

conclusionsClustering of community pharmacies in England is common, although there is a positive trend between community pharmacy clustering and social deprivation, whereby clustering is more significant in areas of high deprivation. Arrangements for future community pharmacy funding should not solely focus on distance from one pharmacy to another as means of determining funding allocation, as this could penalise community pharmacies in our most deprived communities, and potentially have a negative effect on other healthcare providers, such as general practitioner and accident and emergency services.

Indexed as

Community Pharmacy ServicesHealth PolicyEnglandHealth Services AccessibilityHealth Services ResearchHumansPovertyResidence CharacteristicsSpatial AnalysisUrban Populationhealth policyprimary carepublic health

Identifiers

PMID30068619
PMCPMC6074640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.